Evidence map›Paper›PMID 34017072›Full record

ArticleBone marrow transplantation2021

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, Wael Saber, Marcos de Lima, Mark Litzow, Partow Kebriaei, Hisham Abdel-Azim, Kehinde Adekola, Mahmoud Aljurf and 57 more

Abstract readPublished Erratum
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

67 authors.

Mary-Elizabeth PercivalDivision of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@seattlecca.org.ORCID http://orcid.org/0000-0002-7016-951X
Hai-Lin WangCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Mei-Jie ZhangCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Wael SaberCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Marcos de LimaDepartment of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8568-4522
Mark LitzowDivision of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA.
Partow KebriaeiDepartment of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-8607-9404
Hisham Abdel-AzimDivision of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Kehinde AdekolaDivision of Hematology and Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Mahmoud AljurfDepartment of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
Ulrike BacherDepartment of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Sherif M BadawyDivision of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Amer BeitinjanehUniversity of Miami, Miami, FL, USA.
Nelli BejanyanDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0194-7338
Vijaya BhattThe Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.ORCID http://orcid.org/0000-0003-2513-0533
Michael ByrneVanderbilt University Medical Center, Nashville, TN, USA.
Jean-Yves CahnDepartment of Hematology, CHU Grenoble Alpes, Grenoble, France.
Paul CastilloUF Health Shands Children's Hospital, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-2813-1729
Nelson ChaoDepartment of Medicine, Division of Cell Therapy and Hematology, Duke University Medical Center, Durham, NC, USA.
Saurabh ChhabraCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0001-9117-8696
Edward CopelanDepartment of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Corey CutlerCenter for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zachariah DeFilippBlood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7994-8974
Ajoy DiasBeth Israel Deaconess Medical Center, Westwood, KS, USA.
Miguel Angel DiazDepartment of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
Elihu EsteyDivision of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nosha FarhadfarDivision of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Haydar A FrangoulThe Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA.
César O FreytesTexas Transplant Institute, San Antonio, TX, USA.
Robert Peter GaleHaematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
Siddhartha GangulyDivision of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS, USA.
Lohith GowdaYale New Haven Hospital, New Haven, CT, USA.
Michael GrunwaldDepartment of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.ORCID http://orcid.org/0000-0001-5407-9875
Nasheed HossainDepartment of Medicine, Division of Hematology and Oncology, Stem Cell Transplant Program-Loyola University Stritch School of Medicine, Maywood, IL, USA.ORCID http://orcid.org/0000-0002-3278-655X
Rammurti T KambleCenter for Cell and Gene Therapy, Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA.
Christopher G KanakryExperimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ankit KansagraUT Southwestern Medical Center-BMT Program, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-6901-0782
Mohamed A Kharfan-DabajaDivision of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0001-7394-5185
Maxwell KremUniversity of Louisville Hospital/James Brown Cancer Center, Louisville, KY, USA.
Hillard M LazarusUniversity Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-1159-5607
Jong Wook LeeDivision of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Jane L LiesveldDepartment of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Richard LinMemorial Sloan Kettering Cancer Center-Adults, New York, NY, USA.ORCID http://orcid.org/0000-0002-0834-7880
Hongtao LiuUniversity of Chicago Medicine, Chicago, IL, USA.
Joseph McGuirkUniversity of Kansas, Westwood, KS, USA.ORCID http://orcid.org/0000-0002-0539-4796
Reinhold MunkerMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.
Hemant S MurthyDivision of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
Sunita NathanRush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-7920-4265
Taiga NishihoriDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-2621-7924
Richard F OlssonDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Neil PalmisianoSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Jakob R PasswegUniversity Hospital Basel, Basel, Switzerland.
Tim PrestidgeBlood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.ORCID http://orcid.org/0000-0003-4078-5001
Olov RingdénTranslational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-6092-1536
David A RizzieriDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
Witold B RybkaPenn State Hershey Medical Center, Hershey, PA, USA.ORCID http://orcid.org/0000-0003-0396-5804
Mary Lynn SavoieTom Baker Cancer Centre, Calgary, AB, Canada.
Kirk R SchultzDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-0001-6438
Sachiko SeoDepartment of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.ORCID http://orcid.org/0000-0002-4308-2152
Akshay SharmaDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-3281-2081
Melhem SolhThe Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.ORCID http://orcid.org/0000-0003-3766-5623
Roger StrairRutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Marjolein van der PoelMaastricht University Medical Centre, Maastricht, The Netherlands.
Leo F VerdonckDepartment of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
Jean A YaredBlood & Marrow Transplantation Program, Department of Medicine, Division of Hematology and Oncology, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-5346-6299
Daniel WeisdorfDepartment of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.ORCID http://orcid.org/0000-0001-8078-8579
Brenda M SandmaierDivision of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9767-9739

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplantZIABC011659 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KANAKRY, CHRISTOPHER · 2015 to 2025
$18.5M
NCATS NIH HHS UL1 TR001863NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34017072
PMCPMC8450771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.